Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Did the FDA Crush These 3 Biotech Companies?
Motley Fool
Wednesday, October 16, 2013 - 8:15am
tags:
FDA Regulations, Ariad Pharmaceuticals, Achillion, Amarin, Vascepa, sovaprevir, Iclusig
GSK's Reilly assisting anti-bribery authorities in China
Yahoo/Reuters
Wednesday, October 16, 2013 - 8:10am
tags:
GSK, China
Amarin Vascepa FDA Panel Live Blog
TheStreet.com
Wednesday, October 16, 2013 - 8:04am
tags:
FDA, advisory panels, Amarin, Vascepa
Sanofi Cholesterol Drug Beats Merck’s Zetia in Late-Stage Study
Bloomberg
Wednesday, October 16, 2013 - 8:03am
tags:
Sanofi, Zetia, Merck, alirocumab, Regeneron
3 Things to Watch at Amarin's Advisory Committee Meeting
Motley Fool
Wednesday, October 16, 2013 - 8:02am
tags:
Amarin, Vascepa, FDA, advisory panels
Arena Will Double Sales Force For Belviq
Seeking Alpha
Tuesday, October 15, 2013 - 5:13pm
tags:
Arena Pharmaceuticals, Belviq, Eisai, drug reps
Can Protalix Revolutionize This Orphan Disease?
Motley Fool
Tuesday, October 15, 2013 - 5:01pm
tags:
orphan drugs, Protalix BioTherapeutics, Gaucher disease, Vpriv, Shire, Sanofi, Genzyme, Cerezyme, Elelyso
Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg
Tuesday, October 15, 2013 - 4:58pm
tags:
Janssen, Topamax, JNJ, birth defects
3 Ways Q3 Results Show How J&J Is Dramatically Changing
Motley Fool
Tuesday, October 15, 2013 - 4:57pm
tags:
JNJ, earnings
GlaxoSmithKline boss calls for £1bn university fund to back invention
The Guardian, UK
Tuesday, October 15, 2013 - 11:58am
tags:
Andrew Witty, GSK, R&D
New Data Show Omontys At Least 4x Worse Than Reported: Now 22 Suspected Deaths
Seeking Alpha
Tuesday, October 15, 2013 - 11:54am
tags:
Omontys, Affymax, recalls
Arena's Belviq Refill Tracking - Week 17
Seeking Alpha
Tuesday, October 15, 2013 - 11:44am
tags:
Arena Pharmaceuticals, Belviq, Eisai
Roche to supersize biologics production to meet biologics' super forecasts
Fierce Pharma
Tuesday, October 15, 2013 - 11:42am
tags:
Roche, biologics
Sotera lands FDA OK for wireless blood pressure monitor
Mass Device
Tuesday, October 15, 2013 - 11:41am
tags:
Sotera, FDA, wireless blood pressure monitor, devices
Reports: Medical device tax is off the table
Mass Device
Tuesday, October 15, 2013 - 11:38am
tags:
healthcare reform, device tax, devices
Omeros gets approval to study eye surgery drug in children; could extend marketing exclusivity
Yahoo/AP
Tuesday, October 15, 2013 - 11:36am
tags:
Omeros, eye surgery, OMS302
The Chinese Bribery Scandal Is Hurting Big Pharma
Forbes
Tuesday, October 15, 2013 - 11:32am
tags:
China, Big Pharma
4 Biotechnology Stocks With Room To Climb
Seeking Alpha
Tuesday, October 15, 2013 - 10:23am
tags:
Zalicus, Vical, Discovery Labs, Nanosphere
What Drugs? Sanofi Battles Employees In France Over R&D Job Cuts
Pharmalot
Tuesday, October 15, 2013 - 10:21am
tags:
Sanofi, layoffs, R&D
Merck - Little Appeal Despite Recently Announced Cost Cuts
Seeking Alpha
Tuesday, October 15, 2013 - 10:20am
tags:
Merck, Pfizer, Zoetis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.